Skip to main content
Back to Trials
NCT07766161NARecruiting

Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression

University of Michigan

Start Date

7/29/2026

Completion Date

5/1/2027

Summary

The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.

Detailed Description

This study will test a consumer health light therapy device (Re-Timer)

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. ≤ 6 months postpartum 2. EPDS score \>10 Exclusion Criteria: 1. Current or past-year substance use disorder 2. Lifetime history of bipolar disorder or psychotic disorder 3. Active suicidal intent 4. Retinal pathology or history of eye surgery 5. Current use of photosensitizing medications 6. Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy 7. Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted) 8. Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)

Interventions

DEVICE

Light therapy

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Postpartum Depression (PPD)

Locations

University of Michigan

Ann Arbor, Michigan 48109

United States